Biofrontera AG Total Revenue

Biofrontera AG (BFRA) currently reports a total revenue of $28M as of September 2021. That compares with $33M in the prior-year period — down 15.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore Biofrontera AG's total revenue history and peer comparisons.

Biofrontera AG's total revenue decreased from $33M to $28M — a 15.3% year-over-year decrease (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera AG's total revenue of $28M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Biofrontera AG reported $28M in total revenue as of September 2021. That compares with $33M in the prior-year period — down 15.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $28M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for Biofrontera AG, and consider following BFRA for alerts when major investors trade the stock.